Post-translational modifications of NLRP3: to prime or not to prime?
Trends in Immunology · 2026-02 · 47 (2) · 119-129
DOI: 10.1016/j.it.2025.10.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-02. Verfasst von Océane Dufies und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA, USA; Division of Gastroenterology, Harvard Medical School …. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Burroughs Wellcome Fund.
Abstract (Originalsprache)
The NLRP3 inflammasome plays a central role in host defense against microbial infections but also contributes to inflammatory diseases. Functioning of NLRP3 strictly relies on two signals: a 'priming signal' that licenses NLRP3 activity and an 'activation signal' that triggers inflammasome assembly and downstream caspase-1 activation. The priming signal involves transcriptional upregulation of NLRP3 and diverse post-translational modifications that regulate its stability, subcellular localization, and protein-protein interactions. This multilayered regulation prevents untimely inflammasome activation while enabling its rapid assembly when both priming and activation signals are present. Here, we focus on the complexity of the priming signal and critically analyze and discuss how diverse post-translational modifications cooperate to prime NLRP3, controlling its activity in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA, USA; Division of Gastroenterology, Harvard Medical School and Boston Children's Hospital, Boston, MA, USA.
- Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA, USA; Division of Gastroenterology, Harvard Medical School and Boston Children's Hospital, Boston, MA, USA. Electronic address: i…
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Burroughs Wellcome Fund
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Zitieren
APA
Dufies, O., & Zanoni, I. (2026). Post-translational modifications of NLRP3: to prime or not to prime?. Trends in Immunology, 47(2), 119-129. https://doi.org/10.1016/j.it.2025.10.008
Vancouver
Dufies O, Zanoni I. Post-translational modifications of NLRP3: to prime or not to prime?. Trends in Immunology. 2026;47(2):119-129. doi:10.1016/j.it.2025.10.008
BibTeX
@article{Dufies2026,
author = {Dufies, Océane and Zanoni, Ivan},
title = {Post-translational modifications of NLRP3: to prime or not to prime?},
journal = {Trends in Immunology},
year = {2026},
volume = {47},
number = {2},
pages = {119--129},
doi = {10.1016/j.it.2025.10.008}
}
EUVIMED